Sign in

CIK 0001720580

  • Non-accelerated filer
  • Smaller reporting company

Adicet Bio, Inc.

Sign in to watch
Ticker
ACET
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 26
Incorporated
DE
Entity type
Operating
EIN
813305277
Phone
+1 617-482-2333
Business address
131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
Former names
resTORbio, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-06-05 Galimi Francesco SVP & Chief Medical Officer Grant or award · Stock Option (Right to Buy) +375,077 375,077
2024-01-24 Galimi Francesco SVP & Chief Medical Officer Shares withheld for taxes −4,957 $2.40 $12K 75,501
2024-01-24 Galimi Francesco SVP & Chief Medical Officer Grant or award +26,300 101,801
2024-01-24 Galimi Francesco SVP & Chief Medical Officer Grant or award · Stock Option (Right to Buy) +288,134 288,134
2023-10-02 Galimi Francesco SVP & Chief Medical Officer Shares withheld for taxes −8,093 $1.37 $11K 80,458
2023-08-14 Galimi Francesco SVP & Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −113,652 0
2023-08-14 Galimi Francesco SVP & Chief Medical Officer Grant or award · Stock Option (Right to Buy) +113,652 113,652
2023-08-14 Galimi Francesco SVP & Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −77,269 0
2023-08-14 Galimi Francesco SVP & Chief Medical Officer Grant or award · Stock Option (Right to Buy) +77,269 77,269
2023-08-14 Galimi Francesco SVP & Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −73,964 0
2023-08-14 Galimi Francesco SVP & Chief Medical Officer Grant or award · Stock Option (Right to Buy) +73,964 73,964
2023-08-14 Galimi Francesco SVP & Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −26,625 0
2023-08-14 Galimi Francesco SVP & Chief Medical Officer Grant or award · Stock Option (Right to Buy) +26,625 26,625
2023-08-14 Galimi Francesco SVP & Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −125,000 0
2023-08-14 Galimi Francesco SVP & Chief Medical Officer Grant or award · Stock Option (Right to Buy) +125,000 125,000
2023-08-14 Galimi Francesco SVP & Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −117,200 0
2023-08-14 Galimi Francesco SVP & Chief Medical Officer Grant or award · Stock Option (Right to Buy) +117,200 117,200
2023-01-24 Galimi Francesco SVP & Chief Medical Officer Grant or award +26,100 88,551
2023-01-24 Galimi Francesco SVP & Chief Medical Officer Grant or award · Stock Option (Right to Buy) +117,200 117,200
2022-10-04 Galimi Francesco SVP & Chief Medical Officer Shares withheld for taxes −7,933 $14.22 $113K 62,451

Page 1 of 3 · 46 trades